Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group

類似資料

• IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association
  著者:: Debarri, Houria, 等
  出版事項: (2015)
• Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: Results of the ALFA-0701 trial
  著者:: Renneville, Aline, 等
  出版事項: (2014)
• Comprehensive mutational profiling of core binding factor acute myeloid leukemia
  著者:: Duployez, Nicolas, 等
  出版事項: (2016)
• Impact of additional genetic alterations on the outcome of patients with NPM1-mutated cytogenetically normal acute myeloid leukemia
  著者:: Peterlin, Pierre, 等
  出版事項: (2015)
• Clofarabine Improves Relapse-Free Survival of Acute Myeloid Leukemia in Younger Adults with Micro-Complex Karyotype
  著者:: Fenwarth, Laurène, 等
  出版事項: (2019)